title: A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies.
abstract: BACKGROUND
  Depression is a common and distressing problem in the context of dementia, and is significantly more common in Dementia with Lewy bodies (DLB) than in Alzheimer's disease. The neurochemical basis for depression in DLB has not been investigated.
  
  
  OBJECTIVE
  To investigate the association between depression and 5HT transporter re-uptake binding in DLB patients.
  
  
  METHODS
  A representative cohort of dementia patients received annual assessments, which included a standardised evaluation of depression until death. At post-mortem, (3H) cyanoimipramine autoradiography was used to quantify 5HT transporter re-uptake sites in the hippocampus and adjacent temporal cortex (Brodmann Area-BA 36, and 20); and parietal neocortex (BA 7a).
  
  
  RESULTS
  Twenty-one cases were evaluated neurochemically, of whom seven had experienced a major depressive disorder. Major depression was associated with a significant preservation of 5HT transporter re-uptake sites in the parietal neocortex compared with non-affected cases (BA 7a area 1 t = 3.3, P = 0.004; BA 7a area 3 t = 3.8, P = 0.001).
  
  
  CONCLUSIONS
  This preliminary report is important in challenging some of the assumptions about cortical monoamine functioning in depressed dementia.
authors.affiliation: Institute for the Health of the Elderly, University of Newcastle, Newcastle, UK. c.g.ballard@ncl.ac.uk
authors.forename: Clive
authors.initials: C
authors.lastname: Ballard
authors.forename: Mary
authors.initials: M
authors.lastname: Johnson
authors.forename: Margaret
authors.initials: M
authors.lastname: Piggott
authors.forename: Robert
authors.initials: R
authors.lastname: Perry
authors.forename: John
authors.initials: J
authors.lastname: O'Brien
authors.forename: Elise
authors.initials: E
authors.lastname: Rowan
authors.forename: Elaine
authors.initials: E
authors.lastname: Perry
authors.forename: Peter
authors.initials: P
authors.lastname: Lantos
authors.forename: Nigel
authors.initials: N
authors.lastname: Cairns
authors.forename: Clive
authors.initials: C
authors.lastname: Holmes
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001345:Autoradiography; D001665:Binding Sites; D002352:Carrier Proteins / Q000378:metabolism / Q000502:physiology; D003866:Depressive Disorder / Q000150:complications* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007099:Imipramine / Q000031:analogs & derivatives* / Q000378:metabolism; D016631:Lewy Bodies / Q000502:physiology; D020961:Lewy Body Disease / Q000150:complications* / Q000503:physiopathology; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism / Q000502:physiology; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D012701:Serotonin / Q000378:metabolism / Q000502:physiology*; D050486:Serotonin Plasma Membrane Transport Proteins
chemical_list: D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins; C024316:cianopramine; D012701:Serotonin; D007099:Imipramine